Evoke Pharma Inc (EVOK)
5.46
-0.26
(-4.55%)
USD |
NASDAQ |
Nov 05, 11:30
Evoke Pharma Price to Book Value: 1.506 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.577 |
| November 01, 2024 | 1.599 |
| October 31, 2024 | 1.613 |
| October 30, 2024 | 1.778 |
| October 29, 2024 | 1.737 |
| October 28, 2024 | 1.952 |
| October 25, 2024 | 1.461 |
| October 24, 2024 | 1.414 |
| October 23, 2024 | 1.414 |
| October 22, 2024 | 1.489 |
| October 21, 2024 | 1.511 |
| October 18, 2024 | 1.519 |
| October 17, 2024 | 1.471 |
| October 16, 2024 | 1.417 |
| October 15, 2024 | 1.409 |
| October 14, 2024 | 1.403 |
| October 11, 2024 | 1.431 |
| October 10, 2024 | 1.467 |
| October 09, 2024 | 1.426 |
| October 08, 2024 | 1.536 |
| October 07, 2024 | 1.483 |
| October 04, 2024 | 1.448 |
| October 03, 2024 | 1.434 |
| October 02, 2024 | 1.365 |
| October 01, 2024 | 1.343 |
| Date | Value |
|---|---|
| September 30, 2024 | 1.312 |
| September 27, 2024 | 1.326 |
| September 26, 2024 | 1.401 |
| September 25, 2024 | 1.324 |
| September 24, 2024 | 1.379 |
| September 23, 2024 | 1.450 |
| September 20, 2024 | 1.244 |
| September 19, 2024 | 1.224 |
| September 18, 2024 | 1.169 |
| September 17, 2024 | 1.202 |
| September 16, 2024 | 1.164 |
| September 13, 2024 | 1.188 |
| September 12, 2024 | 1.155 |
| September 11, 2024 | 1.108 |
| September 10, 2024 | 1.130 |
| September 09, 2024 | 1.133 |
| September 06, 2024 | 1.067 |
| September 05, 2024 | 1.075 |
| September 04, 2024 | 1.100 |
| September 03, 2024 | 1.140 |
| August 30, 2024 | 1.183 |
| August 29, 2024 | 1.188 |
| August 28, 2024 | 1.212 |
| August 27, 2024 | 1.266 |
| August 26, 2024 | 1.277 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8685
Minimum
Nov 22 2022
32.12
Maximum
Jun 22 2020
5.184
Average
4.877
Median
Price to Book Value Benchmarks
| Repligen Corp | 4.020 |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.086 |
| Theriva Biologics Inc | 0.0780 |
Price to Book Value Related Metrics
| PS Ratio | 0.2590 |
| Price | 5.46 |
| Earnings Yield | -483.5% |
| Market Cap | 4.012M |